Discover
Share the concern, treatment area and change you would like to explore
Loading
Please wait while the page content is assembled.


It is a broad term for treatments involving living cells from sources such as bone marrow, fat or donor tissue. The exact product and processing method must be identified.
It is a broad term for treatments involving living cells from sources such as bone marrow, fat or donor tissue. The exact product and processing method must be identified.
01 / How it works
Knee Stem Cell Therapy Consultation in JB is planned around the treatment area, the technology or product involved and the result you hope to achieve. Your clinician will explain how the approach works and personalise the treatment details for you.
It is a broad term for treatments involving living cells from sources such as bone marrow, fat or donor tissue. The exact product and processing method must be identified.
Share the concern, treatment area and change you would like to explore
Shape the approach around your features, preferences and schedule
Experience a carefully planned session with clear guidance throughout
Follow simple aftercare and review how the treatment is progressing

02 / Visual guide
It is a broad term for treatments involving living cells from sources such as bone marrow, fat or donor tissue. The exact product and processing method must be identified.
Interactive treatment map
Tap a numbered point to move from your concern to the treatment approach, how it works and a personalised plan.

Start with the change you have noticed and the result you would like to explore.
Concerns & areas
Explore common areas and goals, then discuss which are most relevant to you.
Learn how this area can be approached within a personalised treatment plan.
Who may benefit
What to discuss first
03 / Your treatment journey
A calm, well-explained experience at every stage.
Talk through the concern, your previous experiences and the result you would like to explore.
Review the treatment area, suitable options, expected experience and practical timing.
Arrive prepared and receive clear guidance throughout the treatment visit.
Leave with simple aftercare, helpful contact details and a plan for review.
Knee stem-cell therapy is not one standard injection. Products described as stem-cell treatment may come from bone marrow, fat, umbilical-cord tissue, or another source and may contain very different cells, processing methods, and regulatory requirements. Evidence for knee osteoarthritis remains product-specific, and reliable regrowth of lost human knee cartilage has not been established. A cell injection selected for the wrong diagnosis may provide no benefit and delay appropriate care.
Verify the diagnosis, the cells, and the regulatory status before discussing an injection. Our doctor will assess the exact cause of your knee pain, verify the proposed cell product, and review its Malaysian registration. Many patients from Singapore and across Malaysia choose Medi Clinic in Johor Bahru because we prioritise accurate diagnosis, transparent evidence, and patient safety over unverified cartilage-regrowth claims.
04 / Practical expectations
Your experience will reflect the selected treatment, treatment area and individual response. These are the useful details to explore during your visit.
05 / Compare your options
Compare the treatment approach, the area it is designed for, the experience and the way results may develop—not only the name or price.
A useful starting point when you already know the treatment and want to understand it more clearly.
Opens a wider conversation about suitable approaches, timing, recovery and natural-looking results.
Treatment gallery
Explore the consultation, treatment setting and preparation through a carefully selected visual story.
Related concerns
Begin with the concern you notice, then discover treatment approaches and questions worth bringing to your consultation.
Patient knowledge guide
Four short questions explain the treatment, suitability and why assessment matters. This quiz educates—it does not diagnose or confirm treatment eligibility.
06 / Before you decide
Malaysia’s NPRA guidance treats cell and gene therapy products (CGTP) as specialised medicinal products requiring robust safety and efficacy evaluation. We do not state that a cell product is registered merely because it is prepared in a laboratory or has an overseas approval. The exact Malaysian product status must be verified through the NPRA’s QUEST3+ system. Additionally, clinical-trial approval is not the same as routine commercial registration.
Using the patient’s own cells and using donor cells carry different risks. Depending on the product and procedure, possible risks include temporary symptom flare, joint infection, septic arthritis, immune reactions, and treatment failure. Tumourigenicity is also a recognised regulatory concern for some cell products, particularly those that are culture-expanded. A responsible consultation discusses these risks openly, alongside the importance of manufacturing controls and strict batch-release testing.
Read about informed consent07 / Recovery
You will receive treatment-specific guidance on what to expect, how to care for the area and when to contact the clinic with a question.
Contact the clinic08 / FAQ
Helpful answers for planning your consultation and understanding the treatment experience.
Cell therapies are being studied for biological and symptom-related effects, but reliable restoration of substantial lost human knee cartilage has not been established. Selected studies of specific cell products have reported reduced pain and improved function, but study quality varies, and evidence from one product cannot validate another.
It is a broad term for treatments involving living cells from sources such as bone marrow, fat or donor tissue. The exact product and processing method must be identified.
Reliable restoration of substantial lost human knee cartilage has not been established. Pain improvement does not prove structural regeneration.
No. Bone-marrow aspirate concentrate contains a mixture of marrow and blood components and only a small population of progenitor cells.
No. PRP is prepared from blood and contains platelets and plasma rather than a therapeutic stem-cell population.
No guarantee can be made. Advanced joint damage, deformity or major functional limitation may still require surgical assessment.
Plan your next step
Share your goals with the Eco Botanic team and begin with a personalised consultation.